Purchased 875,000 shares of common stock and 2,748,188 pre-funded warrants in the 2025 Private Placement
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
William Ho
Also a director
Chief Executive Officer, Director and Co-Founder
|
50 | Not stated | $953,720 | |
|
Patrick McCall
Chief Financial Officer
|
43 |
Since 2021
5 years
|
$677,196 | |
|
Kate Rochlin, Ph.D.
President and Chief Operating Officer
|
45 | Not stated | $688,850 | |
|
Lawrence Lamb, Ph.D.
EVP and CSO
Title from the Form 4 dated May 9, 2026
|
72 | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchased 875,000 shares of common stock and 2,748,188 pre-funded warrants in the 2025 Private Placement
Purchased 724,637 shares of common stock in the 2025 Private Placement
Purchased 72,464 shares of common stock in the 2025 Private Placement
Purchased 36,232 shares of common stock in the 2025 Private Placement
Purchased 7,247 shares of common stock in the 2025 Private Placement
Purchased 7,247 shares of common stock in the 2025 Private Placement
Purchased 126,818 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 32,963 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 8,994 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 33,755 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 168,776 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 23,634 pre-funded warrants and Series C Warrants in the 2024 Private Placement
Purchased 101,291 pre-funded warrants and Series C Warrants in the 2024 Private Placement
Purchased 8,438 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 4,219 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 843 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 843 shares of common stock and Series C Warrants in the 2024 Private Placement
Purchased 4,219 shares of common stock and Series C Warrants in the 2024 Private Placement
Amended Series A Warrants held by directors and officers (9,971 warrants) and by 5% holders and affiliates (155,751 warrants) to reduce exercise price from $37.50 to $13.50 and extend termination date to October 4, 2025
Surrendered Series A and Series B Warrants for cancellation in exchange for pre-funded warrants and a cash payment of $5.349 per share in the April 2025 Warrant Exchanges
Surrendered Series A and Series B Warrants for cancellation in exchange for pre-funded warrants and a cash payment of $5.529 per share in the April 2025 Warrant Exchanges
Loading...